Nancy Krebs
Concepts (748)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 113 | 2026 | 297 | 15.440 |
Why?
| | Infant Nutritional Physiological Phenomena | 44 | 2026 | 159 | 9.280 |
Why?
| | Dietary Supplements | 61 | 2026 | 580 | 7.960 |
Why?
| | Nutritional Status | 47 | 2026 | 352 | 6.540 |
Why?
| | Micronutrients | 30 | 2026 | 102 | 5.710 |
Why?
| | Maternal Nutritional Physiological Phenomena | 19 | 2026 | 178 | 5.620 |
Why?
| | Developing Countries | 78 | 2026 | 317 | 5.440 |
Why?
| | Diet | 66 | 2026 | 1280 | 5.430 |
Why?
| | Milk, Human | 34 | 2026 | 174 | 5.260 |
Why?
| | Breast Feeding | 48 | 2026 | 447 | 5.060 |
Why?
| | Infant Food | 26 | 2026 | 69 | 4.180 |
Why?
| | Intestinal Absorption | 38 | 2026 | 103 | 3.820 |
Why?
| | Meat | 13 | 2021 | 93 | 3.750 |
Why?
| | Child Development | 23 | 2026 | 484 | 3.600 |
Why?
| | Premature Birth | 26 | 2026 | 387 | 3.470 |
Why?
| | Infant | 163 | 2026 | 10064 | 3.460 |
Why?
| | Iron | 22 | 2026 | 359 | 3.100 |
Why?
| | Infant, Newborn | 128 | 2026 | 6437 | 3.030 |
Why?
| | Nutritional Requirements | 25 | 2019 | 78 | 3.010 |
Why?
| | Pregnancy Outcome | 32 | 2025 | 497 | 2.980 |
Why?
| | Preconception Care | 12 | 2026 | 50 | 2.970 |
Why?
| | Infant Mortality | 37 | 2026 | 128 | 2.950 |
Why?
| | Pregnancy | 143 | 2026 | 7197 | 2.920 |
Why?
| | Food, Fortified | 22 | 2026 | 44 | 2.890 |
Why?
| | Phytic Acid | 19 | 2017 | 35 | 2.650 |
Why?
| | Growth Disorders | 13 | 2026 | 88 | 2.490 |
Why?
| | Anemia, Iron-Deficiency | 11 | 2025 | 62 | 2.470 |
Why?
| | Infant Formula | 12 | 2026 | 71 | 2.320 |
Why?
| | Iron, Dietary | 9 | 2019 | 23 | 2.320 |
Why?
| | Guatemala | 40 | 2026 | 344 | 2.310 |
Why?
| | Prenatal Care | 24 | 2026 | 312 | 2.230 |
Why?
| | Perinatal Death | 13 | 2023 | 26 | 2.190 |
Why?
| | Stillbirth | 26 | 2026 | 81 | 2.180 |
Why?
| | Child Health | 20 | 2023 | 153 | 2.160 |
Why?
| | Female | 281 | 2026 | 78763 | 2.110 |
Why?
| | Fetal Development | 8 | 2026 | 297 | 2.000 |
Why?
| | Azithromycin | 11 | 2026 | 105 | 1.990 |
Why?
| | Humans | 359 | 2026 | 145491 | 1.980 |
Why?
| | Poverty | 13 | 2023 | 525 | 1.920 |
Why?
| | Lactation | 16 | 2025 | 193 | 1.890 |
Why?
| | Obesity, Morbid | 7 | 2021 | 288 | 1.810 |
Why?
| | Pregnancy Complications, Infectious | 12 | 2026 | 437 | 1.810 |
Why?
| | Dietary Proteins | 12 | 2026 | 135 | 1.810 |
Why?
| | Dairy Products | 3 | 2021 | 30 | 1.750 |
Why?
| | Pakistan | 33 | 2026 | 79 | 1.740 |
Why?
| | Energy Intake | 15 | 2026 | 506 | 1.740 |
Why?
| | Homeostasis | 21 | 2015 | 639 | 1.720 |
Why?
| | Infant Health | 10 | 2023 | 25 | 1.710 |
Why?
| | Obesity | 24 | 2024 | 3076 | 1.710 |
Why?
| | Feces | 28 | 2026 | 514 | 1.700 |
Why?
| | Cesarean Section | 8 | 2021 | 230 | 1.680 |
Why?
| | Body Mass Index | 23 | 2023 | 2425 | 1.610 |
Why?
| | Delivery, Obstetric | 20 | 2026 | 161 | 1.580 |
Why?
| | Gastric Bypass | 6 | 2019 | 126 | 1.580 |
Why?
| | Trace Elements | 13 | 2022 | 52 | 1.550 |
Why?
| | Infant, Small for Gestational Age | 8 | 2026 | 117 | 1.530 |
Why?
| | Mothers | 13 | 2024 | 767 | 1.470 |
Why?
| | Pregnancy Complications | 17 | 2025 | 612 | 1.450 |
Why?
| | Birth Weight | 23 | 2025 | 511 | 1.440 |
Why?
| | Maternal Mortality | 18 | 2025 | 53 | 1.400 |
Why?
| | Gastrointestinal Microbiome | 10 | 2025 | 774 | 1.360 |
Why?
| | Anemia | 10 | 2026 | 190 | 1.340 |
Why?
| | Malnutrition | 6 | 2026 | 86 | 1.310 |
Why?
| | Growth | 7 | 2020 | 49 | 1.240 |
Why?
| | Adult | 123 | 2026 | 40707 | 1.240 |
Why?
| | Maternal Health | 6 | 2023 | 50 | 1.200 |
Why?
| | Zea mays | 12 | 2017 | 43 | 1.180 |
Why?
| | Nutrition Assessment | 5 | 2025 | 92 | 1.160 |
Why?
| | Anthropometry | 13 | 2024 | 205 | 1.160 |
Why?
| | Gestational Age | 17 | 2026 | 988 | 1.160 |
Why?
| | Infant, Premature | 9 | 2023 | 619 | 1.140 |
Why?
| | Child, Preschool | 55 | 2026 | 11837 | 1.120 |
Why?
| | Infant, Low Birth Weight | 15 | 2026 | 156 | 1.120 |
Why?
| | India | 22 | 2026 | 220 | 1.110 |
Why?
| | Child | 71 | 2024 | 22680 | 1.100 |
Why?
| | Zinc Isotopes | 22 | 2011 | 22 | 1.100 |
Why?
| | Child Nutritional Physiological Phenomena | 9 | 2019 | 106 | 1.090 |
Why?
| | Weaning | 7 | 2026 | 51 | 1.090 |
Why?
| | Gastrectomy | 3 | 2021 | 162 | 1.040 |
Why?
| | Anti-Bacterial Agents | 10 | 2026 | 1953 | 1.030 |
Why?
| | Pre-Eclampsia | 5 | 2023 | 206 | 1.010 |
Why?
| | Prospective Studies | 51 | 2026 | 8039 | 1.000 |
Why?
| | Feeding Behavior | 12 | 2023 | 694 | 1.000 |
Why?
| | Zambia | 19 | 2026 | 58 | 0.990 |
Why?
| | Rural Population | 18 | 2022 | 658 | 0.990 |
Why?
| | Biological Availability | 22 | 2022 | 144 | 0.980 |
Why?
| | Biomarkers | 23 | 2026 | 4283 | 0.970 |
Why?
| | Nutritional Sciences | 5 | 2019 | 34 | 0.970 |
Why?
| | Body Composition | 10 | 2025 | 689 | 0.960 |
Why?
| | Democratic Republic of the Congo | 16 | 2026 | 34 | 0.940 |
Why?
| | Male | 126 | 2026 | 72817 | 0.940 |
Why?
| | Food | 3 | 2020 | 150 | 0.940 |
Why?
| | Registries | 28 | 2026 | 2410 | 0.930 |
Why?
| | Young Adult | 59 | 2026 | 14192 | 0.920 |
Why?
| | Double-Blind Method | 23 | 2026 | 2060 | 0.910 |
Why?
| | Vitamins | 4 | 2025 | 180 | 0.900 |
Why?
| | Perinatal Mortality | 11 | 2026 | 23 | 0.890 |
Why?
| | Weight Gain | 10 | 2026 | 557 | 0.850 |
Why?
| | Birth Intervals | 2 | 2021 | 23 | 0.840 |
Why?
| | Postpartum Period | 7 | 2026 | 373 | 0.840 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 27 | 0.830 |
Why?
| | Powders | 10 | 2025 | 44 | 0.810 |
Why?
| | Premenopause | 3 | 2021 | 123 | 0.780 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 111 | 0.770 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2021 | 26 | 0.760 |
Why?
| | Maternal Health Services | 6 | 2019 | 102 | 0.750 |
Why?
| | Women's Health | 13 | 2023 | 308 | 0.750 |
Why?
| | Aspirin | 8 | 2026 | 407 | 0.750 |
Why?
| | Education, Medical | 4 | 2019 | 273 | 0.750 |
Why?
| | Hemoglobins | 8 | 2025 | 386 | 0.740 |
Why?
| | Sodium Chloride, Dietary | 4 | 2026 | 31 | 0.730 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 39 | 0.720 |
Why?
| | Antibiotic Prophylaxis | 5 | 2026 | 134 | 0.720 |
Why?
| | Nutritive Value | 4 | 2026 | 43 | 0.720 |
Why?
| | Inflammation | 7 | 2026 | 2883 | 0.720 |
Why?
| | Vegetables | 2 | 2022 | 162 | 0.720 |
Why?
| | Obstetric Labor Complications | 6 | 2020 | 38 | 0.720 |
Why?
| | Overweight | 7 | 2023 | 607 | 0.700 |
Why?
| | Edible Grain | 7 | 2014 | 48 | 0.690 |
Why?
| | Cesarean Section, Repeat | 1 | 2021 | 11 | 0.690 |
Why?
| | Bangladesh | 10 | 2026 | 63 | 0.680 |
Why?
| | Weight Reduction Programs | 2 | 2013 | 138 | 0.670 |
Why?
| | Sepsis | 5 | 2026 | 661 | 0.670 |
Why?
| | Body Height | 6 | 2022 | 200 | 0.660 |
Why?
| | Deficiency Diseases | 6 | 2019 | 10 | 0.630 |
Why?
| | Models, Biological | 9 | 2016 | 1815 | 0.630 |
Why?
| | Recommended Dietary Allowances | 3 | 2018 | 16 | 0.620 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.620 |
Why?
| | Milk Banks | 1 | 2019 | 1 | 0.610 |
Why?
| | Longitudinal Studies | 21 | 2026 | 2950 | 0.610 |
Why?
| | Ultrasonography, Prenatal | 6 | 2020 | 294 | 0.610 |
Why?
| | Health Education | 4 | 2018 | 345 | 0.600 |
Why?
| | Adolescent | 48 | 2025 | 22485 | 0.600 |
Why?
| | Malabsorption Syndromes | 1 | 2019 | 15 | 0.600 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.590 |
Why?
| | Dietary Fats | 2 | 2020 | 308 | 0.580 |
Why?
| | Kenya | 12 | 2026 | 130 | 0.580 |
Why?
| | Iron Metabolism Disorders | 2 | 2015 | 6 | 0.580 |
Why?
| | Maternal Death | 4 | 2020 | 15 | 0.570 |
Why?
| | Developed Countries | 2 | 2015 | 38 | 0.570 |
Why?
| | Organic Chemicals | 1 | 2020 | 126 | 0.560 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 343 | 0.560 |
Why?
| | Prevalence | 15 | 2026 | 2855 | 0.550 |
Why?
| | Avitaminosis | 1 | 2018 | 6 | 0.550 |
Why?
| | Nutrition Therapy | 2 | 2019 | 37 | 0.550 |
Why?
| | Parity | 8 | 2023 | 109 | 0.550 |
Why?
| | Malaria | 1 | 2019 | 73 | 0.550 |
Why?
| | Metabolomics | 2 | 2021 | 729 | 0.540 |
Why?
| | Enteritis | 1 | 2019 | 104 | 0.540 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 565 | 0.530 |
Why?
| | Body Size | 6 | 2019 | 95 | 0.530 |
Why?
| | Body Weight | 13 | 2019 | 970 | 0.510 |
Why?
| | Diarrhea | 5 | 2022 | 194 | 0.510 |
Why?
| | Weight Loss | 2 | 2013 | 839 | 0.500 |
Why?
| | Insulin | 7 | 2021 | 2506 | 0.490 |
Why?
| | Metabolome | 1 | 2020 | 387 | 0.480 |
Why?
| | Cross-Sectional Studies | 27 | 2026 | 5891 | 0.470 |
Why?
| | Leptin | 5 | 2018 | 248 | 0.470 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.470 |
Why?
| | Global Health | 10 | 2025 | 404 | 0.470 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 7 | 0.460 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.440 |
Why?
| | Starch | 1 | 2015 | 22 | 0.440 |
Why?
| | Nutrition Policy | 6 | 2017 | 58 | 0.440 |
Why?
| | Pregnancy Trimester, First | 7 | 2023 | 138 | 0.430 |
Why?
| | Labor, Obstetric | 4 | 2026 | 68 | 0.430 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 55 | 0.430 |
Why?
| | Risk Factors | 27 | 2026 | 10874 | 0.430 |
Why?
| | Brain | 2 | 2017 | 2944 | 0.420 |
Why?
| | Calcium | 5 | 2022 | 1190 | 0.420 |
Why?
| | Oryza | 2 | 2026 | 32 | 0.420 |
Why?
| | Infant, Premature, Diseases | 1 | 2015 | 113 | 0.410 |
Why?
| | Adiposity | 3 | 2018 | 529 | 0.410 |
Why?
| | Cohort Studies | 14 | 2021 | 5992 | 0.410 |
Why?
| | Intestinal Diseases | 2 | 2026 | 43 | 0.410 |
Why?
| | Age Factors | 9 | 2015 | 3340 | 0.410 |
Why?
| | Health Promotion | 4 | 2023 | 775 | 0.410 |
Why?
| | Aging | 6 | 2018 | 1940 | 0.410 |
Why?
| | Educational Status | 11 | 2022 | 465 | 0.400 |
Why?
| | Calcium, Dietary | 5 | 2022 | 52 | 0.400 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.400 |
Why?
| | Socioeconomic Factors | 13 | 2024 | 1327 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 10 | 2026 | 1755 | 0.390 |
Why?
| | Pediatrics | 6 | 2018 | 1121 | 0.390 |
Why?
| | Income | 9 | 2023 | 201 | 0.390 |
Why?
| | Regression Analysis | 10 | 2016 | 1001 | 0.390 |
Why?
| | Dysprosium | 2 | 2010 | 2 | 0.380 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.370 |
Why?
| | Flour | 4 | 2015 | 6 | 0.370 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2023 | 69 | 0.370 |
Why?
| | Occupational Health Services | 1 | 2012 | 37 | 0.370 |
Why?
| | Pregnancy Trimester, Third | 3 | 2017 | 118 | 0.360 |
Why?
| | Triticum | 2 | 2009 | 19 | 0.350 |
Why?
| | Metagenome | 1 | 2013 | 149 | 0.350 |
Why?
| | Heme | 1 | 2012 | 89 | 0.350 |
Why?
| | Glucocorticoids | 4 | 2016 | 531 | 0.350 |
Why?
| | Dietary Carbohydrates | 2 | 2010 | 147 | 0.350 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 226 | 0.350 |
Why?
| | Protein Hydrolysates | 2 | 2002 | 6 | 0.350 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2021 | 317 | 0.350 |
Why?
| | Caseins | 2 | 2002 | 20 | 0.340 |
Why?
| | Maternal Age | 12 | 2020 | 126 | 0.340 |
Why?
| | Social Class | 3 | 2022 | 265 | 0.340 |
Why?
| | Iodine | 4 | 2026 | 27 | 0.340 |
Why?
| | Intestinal Mucosa | 7 | 2018 | 675 | 0.340 |
Why?
| | Administration, Oral | 9 | 2026 | 863 | 0.340 |
Why?
| | Diet Records | 6 | 2026 | 89 | 0.330 |
Why?
| | Folic Acid | 5 | 2026 | 198 | 0.330 |
Why?
| | Public Health | 4 | 2025 | 573 | 0.320 |
Why?
| | Zika Virus Infection | 2 | 2025 | 172 | 0.320 |
Why?
| | Cross-Over Studies | 7 | 2026 | 607 | 0.320 |
Why?
| | Failure to Thrive | 3 | 2009 | 28 | 0.320 |
Why?
| | Maternal-Child Health Services | 3 | 2019 | 12 | 0.320 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 208 | 0.320 |
Why?
| | Wasting Syndrome | 1 | 2010 | 12 | 0.310 |
Why?
| | Workplace | 1 | 2012 | 272 | 0.310 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.310 |
Why?
| | Biological Transport | 3 | 2021 | 422 | 0.310 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2185 | 0.310 |
Why?
| | Nutritional Physiological Phenomena | 4 | 2022 | 56 | 0.300 |
Why?
| | Logistic Models | 5 | 2026 | 2130 | 0.300 |
Why?
| | Nutrition Surveys | 1 | 2011 | 280 | 0.300 |
Why?
| | Asphyxia Neonatorum | 2 | 2026 | 21 | 0.300 |
Why?
| | Time Factors | 9 | 2021 | 7171 | 0.300 |
Why?
| | Absorption | 11 | 2013 | 61 | 0.290 |
Why?
| | Quality Indicators, Health Care | 1 | 2012 | 336 | 0.290 |
Why?
| | Staining and Labeling | 1 | 2009 | 153 | 0.290 |
Why?
| | Fetus | 4 | 2021 | 804 | 0.280 |
Why?
| | Neonatal Sepsis | 2 | 2026 | 9 | 0.280 |
Why?
| | Medically Underserved Area | 3 | 2018 | 100 | 0.280 |
Why?
| | Environment | 3 | 2026 | 307 | 0.270 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.270 |
Why?
| | Patient Safety | 1 | 2012 | 357 | 0.270 |
Why?
| | Selenium | 2 | 2025 | 50 | 0.270 |
Why?
| | Latin America | 7 | 2026 | 97 | 0.270 |
Why?
| | Follow-Up Studies | 8 | 2026 | 5426 | 0.270 |
Why?
| | Lipids | 2 | 2024 | 709 | 0.260 |
Why?
| | Asia | 7 | 2026 | 72 | 0.260 |
Why?
| | Practice Guidelines as Topic | 4 | 2016 | 1585 | 0.260 |
Why?
| | Cytokines | 3 | 2021 | 2054 | 0.250 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2023 | 1417 | 0.250 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 308 | 0.250 |
Why?
| | Folic Acid Deficiency | 2 | 2025 | 49 | 0.250 |
Why?
| | Adiponectin | 2 | 2018 | 240 | 0.240 |
Why?
| | Urinalysis | 5 | 2020 | 83 | 0.240 |
Why?
| | Pediatric Obesity | 3 | 2023 | 637 | 0.240 |
Why?
| | Fast Foods | 1 | 2026 | 22 | 0.240 |
Why?
| | Minerals | 2 | 2025 | 48 | 0.240 |
Why?
| | Dietary Sugars | 1 | 2026 | 21 | 0.240 |
Why?
| | Sodium, Dietary | 1 | 2026 | 42 | 0.240 |
Why?
| | Communicable Diseases | 2 | 2023 | 166 | 0.240 |
Why?
| | Africa | 6 | 2026 | 119 | 0.230 |
Why?
| | Deoxyglucose | 1 | 2026 | 49 | 0.230 |
Why?
| | Referral and Consultation | 3 | 2019 | 862 | 0.230 |
Why?
| | Health Personnel | 3 | 2023 | 750 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Postpartum Hemorrhage | 1 | 2026 | 28 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Bone and Bones | 2 | 2019 | 318 | 0.220 |
Why?
| | Cause of Death | 2 | 2018 | 469 | 0.220 |
Why?
| | Colorado | 7 | 2017 | 4572 | 0.220 |
Why?
| | Vitamin B 12 | 4 | 2026 | 127 | 0.220 |
Why?
| | Risk Assessment | 7 | 2018 | 3759 | 0.220 |
Why?
| | Perinatal Care | 2 | 2018 | 62 | 0.220 |
Why?
| | Schools, Medical | 1 | 2006 | 159 | 0.220 |
Why?
| | Drug Resistance, Bacterial | 1 | 2026 | 206 | 0.210 |
Why?
| | Microcephaly | 1 | 2025 | 105 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1265 | 0.210 |
Why?
| | Saliva | 2 | 2026 | 247 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2026 | 180 | 0.210 |
Why?
| | Maternal Welfare | 2 | 2014 | 22 | 0.210 |
Why?
| | Parents | 1 | 2013 | 1404 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Feasibility Studies | 4 | 2023 | 1119 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2026 | 194 | 0.200 |
Why?
| | Retrospective Studies | 9 | 2023 | 17269 | 0.200 |
Why?
| | Reference Values | 4 | 2022 | 797 | 0.200 |
Why?
| | China | 5 | 2014 | 271 | 0.200 |
Why?
| | Climate Change | 1 | 2026 | 203 | 0.200 |
Why?
| | Ferritins | 2 | 2016 | 70 | 0.190 |
Why?
| | Milk | 3 | 2018 | 119 | 0.190 |
Why?
| | Erythrocytes | 5 | 2022 | 751 | 0.190 |
Why?
| | United States | 15 | 2026 | 16115 | 0.190 |
Why?
| | Food Assistance | 1 | 2023 | 29 | 0.190 |
Why?
| | Soybean Proteins | 1 | 2002 | 15 | 0.190 |
Why?
| | Vitamin A | 1 | 2023 | 60 | 0.190 |
Why?
| | Vitamin K | 1 | 2023 | 46 | 0.190 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2002 | 24 | 0.190 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 102 | 0.190 |
Why?
| | Labor Presentation | 2 | 2019 | 2 | 0.190 |
Why?
| | Plant Oils | 1 | 2002 | 34 | 0.190 |
Why?
| | Infant Care | 2 | 2015 | 44 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2006 | 301 | 0.190 |
Why?
| | Pandemics | 4 | 2024 | 1706 | 0.190 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 107 | 0.190 |
Why?
| | Temperature | 2 | 2023 | 681 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 254 | 0.180 |
Why?
| | Health Facilities | 2 | 2020 | 86 | 0.180 |
Why?
| | Drug Monitoring | 1 | 2026 | 400 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2019 | 2030 | 0.180 |
Why?
| | Puerperal Infection | 3 | 2024 | 5 | 0.180 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 651 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2016 | 482 | 0.180 |
Why?
| | Africa South of the Sahara | 5 | 2026 | 54 | 0.180 |
Why?
| | Adolescent Health | 2 | 2019 | 37 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2026 | 376 | 0.180 |
Why?
| | Postnatal Care | 2 | 2020 | 76 | 0.180 |
Why?
| | Staphylococcus aureus | 1 | 2026 | 455 | 0.180 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2026 | 505 | 0.180 |
Why?
| | Fatty Acids | 3 | 2022 | 459 | 0.170 |
Why?
| | Zinc Oxide | 3 | 2012 | 9 | 0.170 |
Why?
| | Midwifery | 3 | 2014 | 66 | 0.170 |
Why?
| | Tobacco, Smokeless | 1 | 2021 | 13 | 0.170 |
Why?
| | Bone Density | 3 | 2006 | 484 | 0.170 |
Why?
| | Biomedical Research | 3 | 2017 | 718 | 0.170 |
Why?
| | Rural Health | 5 | 2016 | 87 | 0.170 |
Why?
| | Patient Dropouts | 2 | 2012 | 65 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2024 | 217 | 0.170 |
Why?
| | Students | 1 | 2007 | 658 | 0.170 |
Why?
| | Tablets | 4 | 2022 | 41 | 0.170 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.170 |
Why?
| | Isoleucine | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiration, Artificial | 1 | 2026 | 712 | 0.170 |
Why?
| | Birth Rate | 1 | 2020 | 28 | 0.170 |
Why?
| | Selenoproteins | 1 | 2020 | 7 | 0.170 |
Why?
| | Cystic Fibrosis | 3 | 2000 | 1173 | 0.160 |
Why?
| | Animals | 17 | 2025 | 38141 | 0.160 |
Why?
| | Health Status | 1 | 2026 | 836 | 0.160 |
Why?
| | Valine | 1 | 2021 | 82 | 0.160 |
Why?
| | Phenylalanine | 1 | 2021 | 70 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2021 | 114 | 0.160 |
Why?
| | Digestive System Physiological Phenomena | 1 | 2000 | 5 | 0.160 |
Why?
| | Leucine | 1 | 2021 | 116 | 0.160 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.160 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 6070 | 0.160 |
Why?
| | Parturition | 1 | 2021 | 68 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2018 | 11831 | 0.160 |
Why?
| | Oligohydramnios | 1 | 2020 | 16 | 0.160 |
Why?
| | Linear Models | 4 | 2016 | 848 | 0.150 |
Why?
| | Biotransformation | 1 | 2020 | 63 | 0.150 |
Why?
| | Cleft Lip | 1 | 2020 | 72 | 0.150 |
Why?
| | Endotoxemia | 1 | 2020 | 86 | 0.150 |
Why?
| | Quality of Health Care | 3 | 2020 | 693 | 0.150 |
Why?
| | Pasteurization | 1 | 2019 | 3 | 0.150 |
Why?
| | Digestion | 2 | 2017 | 10 | 0.150 |
Why?
| | Spouses | 1 | 2021 | 108 | 0.150 |
Why?
| | Thinness | 2 | 2018 | 99 | 0.150 |
Why?
| | Leukocyte L1 Antigen Complex | 2 | 2026 | 41 | 0.150 |
Why?
| | International Classification of Diseases | 1 | 2020 | 148 | 0.150 |
Why?
| | Diet, Fat-Restricted | 1 | 2000 | 79 | 0.150 |
Why?
| | Lactulose | 1 | 2019 | 2 | 0.150 |
Why?
| | Cleft Palate | 1 | 2020 | 90 | 0.150 |
Why?
| | Polyhydramnios | 1 | 2019 | 17 | 0.150 |
Why?
| | Liver | 6 | 2020 | 1895 | 0.150 |
Why?
| | Calorimetry | 1 | 2019 | 69 | 0.150 |
Why?
| | Health Resources | 1 | 2020 | 130 | 0.150 |
Why?
| | Mannitol | 1 | 2019 | 40 | 0.150 |
Why?
| | Intestines | 3 | 2019 | 357 | 0.150 |
Why?
| | Cholesterol, HDL | 2 | 2023 | 200 | 0.150 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 179 | 0.150 |
Why?
| | Hepcidins | 1 | 2019 | 21 | 0.150 |
Why?
| | Endemic Diseases | 1 | 2019 | 33 | 0.140 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 318 | 0.140 |
Why?
| | Hypersensitivity, Immediate | 1 | 2019 | 41 | 0.140 |
Why?
| | Pilot Projects | 3 | 2023 | 1896 | 0.140 |
Why?
| | Malawi | 4 | 2015 | 57 | 0.140 |
Why?
| | Beverages | 4 | 2019 | 68 | 0.140 |
Why?
| | Species Specificity | 1 | 2020 | 573 | 0.140 |
Why?
| | Ghrelin | 1 | 2018 | 42 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 72 | 0.140 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 53 | 0.140 |
Why?
| | Middle Aged | 10 | 2025 | 36176 | 0.140 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 32 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 200 | 0.140 |
Why?
| | Glucose | 3 | 2023 | 1039 | 0.140 |
Why?
| | Meat Products | 2 | 2012 | 27 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2017 | 1350 | 0.140 |
Why?
| | Erythrocyte Indices | 2 | 2021 | 33 | 0.140 |
Why?
| | Exercise | 7 | 2023 | 2192 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 581 | 0.130 |
Why?
| | Proteobacteria | 1 | 2017 | 16 | 0.130 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.130 |
Why?
| | Clostridium | 1 | 2017 | 19 | 0.130 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 452 | 0.130 |
Why?
| | Food Supply | 1 | 2018 | 85 | 0.130 |
Why?
| | Indians, Central American | 1 | 2017 | 6 | 0.130 |
Why?
| | Cluster Analysis | 5 | 2019 | 517 | 0.130 |
Why?
| | Postoperative Complications | 2 | 2009 | 2962 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 388 | 0.130 |
Why?
| | Isotopes | 1 | 2017 | 34 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 270 | 0.130 |
Why?
| | Infusions, Intravenous | 3 | 2006 | 427 | 0.130 |
Why?
| | Head | 2 | 2010 | 121 | 0.120 |
Why?
| | Food Analysis | 2 | 2015 | 24 | 0.120 |
Why?
| | Copper | 3 | 2004 | 114 | 0.120 |
Why?
| | Professional-Family Relations | 1 | 2018 | 153 | 0.120 |
Why?
| | Appetite | 2 | 2010 | 79 | 0.120 |
Why?
| | Gene Expression | 1 | 2021 | 1478 | 0.120 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.120 |
Why?
| | Communication | 1 | 2023 | 975 | 0.120 |
Why?
| | Social Determinants of Health | 1 | 2020 | 308 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2016 | 50 | 0.120 |
Why?
| | Interleukin-8 | 1 | 2017 | 269 | 0.120 |
Why?
| | Biomedical Technology | 1 | 2017 | 49 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 96 | 0.120 |
Why?
| | Intensive Care, Neonatal | 1 | 2016 | 43 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 616 | 0.120 |
Why?
| | Blood Pressure | 2 | 2020 | 1782 | 0.120 |
Why?
| | Population Surveillance | 4 | 2020 | 485 | 0.120 |
Why?
| | Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.120 |
Why?
| | Pneumonia | 3 | 2009 | 632 | 0.110 |
Why?
| | Ethiopia | 4 | 2009 | 44 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 141 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3424 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2021 | 1244 | 0.110 |
Why?
| | Overnutrition | 1 | 2015 | 28 | 0.110 |
Why?
| | World Health Organization | 3 | 2012 | 104 | 0.110 |
Why?
| | Data Accuracy | 1 | 2015 | 65 | 0.110 |
Why?
| | Haemophilus influenzae type b | 1 | 2014 | 12 | 0.110 |
Why?
| | Diabetes Mellitus | 4 | 2016 | 1076 | 0.110 |
Why?
| | Bacterial Capsules | 1 | 2014 | 33 | 0.110 |
Why?
| | American Heart Association | 1 | 2016 | 360 | 0.110 |
Why?
| | Haemophilus Vaccines | 1 | 2014 | 29 | 0.110 |
Why?
| | Drug Utilization | 3 | 2024 | 167 | 0.110 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 217 | 0.110 |
Why?
| | Multivariate Analysis | 5 | 2020 | 1544 | 0.110 |
Why?
| | Antibody Affinity | 1 | 2014 | 60 | 0.110 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 82 | 0.110 |
Why?
| | Chile | 2 | 2012 | 27 | 0.100 |
Why?
| | Contraception Behavior | 1 | 2015 | 108 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 831 | 0.100 |
Why?
| | Family Planning Services | 1 | 2015 | 93 | 0.100 |
Why?
| | Placenta | 1 | 2021 | 784 | 0.100 |
Why?
| | Life Style | 2 | 2015 | 483 | 0.100 |
Why?
| | Stroke | 1 | 2023 | 1272 | 0.100 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 645 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2016 | 247 | 0.100 |
Why?
| | Up-Regulation | 1 | 2017 | 848 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 344 | 0.100 |
Why?
| | Food Preferences | 1 | 2015 | 126 | 0.100 |
Why?
| | Algorithms | 3 | 2017 | 1855 | 0.100 |
Why?
| | Antibodies, Bacterial | 1 | 2014 | 147 | 0.100 |
Why?
| | Pennisetum | 1 | 2013 | 2 | 0.100 |
Why?
| | Hair | 3 | 2011 | 86 | 0.100 |
Why?
| | Central America | 2 | 2025 | 25 | 0.100 |
Why?
| | Acrodermatitis | 1 | 2013 | 1 | 0.100 |
Why?
| | Population Groups | 1 | 2013 | 56 | 0.100 |
Why?
| | Alkaline Phosphatase | 3 | 2011 | 144 | 0.100 |
Why?
| | Pregnancy, Multiple | 1 | 2013 | 18 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 279 | 0.100 |
Why?
| | Qualitative Research | 1 | 2021 | 1677 | 0.100 |
Why?
| | Neonatology | 1 | 2013 | 32 | 0.100 |
Why?
| | Indicator Dilution Techniques | 4 | 2006 | 12 | 0.100 |
Why?
| | Liver Diseases | 3 | 2013 | 304 | 0.100 |
Why?
| | Puerperal Disorders | 3 | 2020 | 37 | 0.090 |
Why?
| | Health Services Accessibility | 2 | 2019 | 1101 | 0.090 |
Why?
| | Prolactin | 2 | 2007 | 87 | 0.090 |
Why?
| | Needs Assessment | 2 | 2015 | 401 | 0.090 |
Why?
| | Iron Radioisotopes | 1 | 2012 | 2 | 0.090 |
Why?
| | Puerto Rico | 2 | 2025 | 59 | 0.090 |
Why?
| | Escherichia coli | 1 | 2017 | 857 | 0.090 |
Why?
| | Endocrine System | 1 | 2012 | 22 | 0.090 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 593 | 0.090 |
Why?
| | Poverty Areas | 1 | 2012 | 43 | 0.090 |
Why?
| | Urban Health | 1 | 2012 | 96 | 0.090 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 64 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| | Triglycerides | 1 | 2014 | 518 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 68 | 0.090 |
Why?
| | Intestine, Small | 2 | 2011 | 167 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2002 | 1304 | 0.090 |
Why?
| | Ferrous Compounds | 3 | 2026 | 26 | 0.090 |
Why?
| | Erythrocyte Membrane | 1 | 2011 | 54 | 0.080 |
Why?
| | Obstetrics | 1 | 2013 | 176 | 0.080 |
Why?
| | Morphogenesis | 1 | 2012 | 172 | 0.080 |
Why?
| | Zika Virus | 2 | 2025 | 136 | 0.080 |
Why?
| | Cerebrovascular Disorders | 1 | 2012 | 106 | 0.080 |
Why?
| | Clinical Competence | 1 | 2019 | 1242 | 0.080 |
Why?
| | Chickens | 1 | 2011 | 184 | 0.080 |
Why?
| | International Agencies | 1 | 2011 | 30 | 0.080 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 5 | 0.080 |
Why?
| | Incidence | 4 | 2019 | 2915 | 0.080 |
Why?
| | Digestive System | 2 | 2001 | 29 | 0.080 |
Why?
| | Curriculum | 3 | 2019 | 1068 | 0.080 |
Why?
| | Single-Blind Method | 1 | 2011 | 319 | 0.080 |
Why?
| | Growth Charts | 1 | 2010 | 20 | 0.080 |
Why?
| | Inositol Phosphates | 1 | 2010 | 21 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 366 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2014 | 772 | 0.080 |
Why?
| | Food, Formulated | 1 | 1989 | 16 | 0.080 |
Why?
| | Argentina | 3 | 2014 | 30 | 0.080 |
Why?
| | Language | 1 | 2013 | 323 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2014 | 909 | 0.080 |
Why?
| | Family Nursing | 1 | 2009 | 12 | 0.080 |
Why?
| | Physicians | 2 | 2019 | 952 | 0.080 |
Why?
| | Manganese | 1 | 1989 | 55 | 0.080 |
Why?
| | Public Assistance | 1 | 2009 | 20 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1212 | 0.070 |
Why?
| | Child Welfare | 1 | 2012 | 233 | 0.070 |
Why?
| | Program Evaluation | 1 | 2014 | 945 | 0.070 |
Why?
| | Blood Glucose | 2 | 2021 | 2330 | 0.070 |
Why?
| | Respiratory Hypersensitivity | 1 | 2009 | 65 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 234 | 0.070 |
Why?
| | Cattle | 2 | 2024 | 977 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 884 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 587 | 0.070 |
Why?
| | Congo | 2 | 2020 | 4 | 0.070 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 557 | 0.070 |
Why?
| | Celiac Disease | 1 | 2011 | 310 | 0.070 |
Why?
| | Health Planning Guidelines | 1 | 2007 | 24 | 0.070 |
Why?
| | Ascorbic Acid | 1 | 2009 | 175 | 0.070 |
Why?
| | Safety | 1 | 2010 | 357 | 0.070 |
Why?
| | Urban Population | 3 | 2018 | 494 | 0.070 |
Why?
| | Food Handling | 2 | 2025 | 63 | 0.070 |
Why?
| | Nutrition Disorders | 1 | 2007 | 20 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 654 | 0.070 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 60 | 0.060 |
Why?
| | Child Behavior | 1 | 2009 | 236 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1269 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2582 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 4093 | 0.060 |
Why?
| | Injections, Intravenous | 3 | 2004 | 199 | 0.060 |
Why?
| | Cognition | 2 | 2009 | 1268 | 0.060 |
Why?
| | Diphosphates | 1 | 2026 | 20 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 2002 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2002 | 733 | 0.060 |
Why?
| | Sex Factors | 2 | 2010 | 2110 | 0.060 |
Why?
| | Edetic Acid | 1 | 2026 | 46 | 0.060 |
Why?
| | Research Design | 2 | 2019 | 1134 | 0.060 |
Why?
| | Blood Transfusion | 2 | 2026 | 408 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1020 | 0.060 |
Why?
| | Peroxidase | 1 | 2026 | 168 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 452 | 0.060 |
Why?
| | Aged | 3 | 2023 | 26125 | 0.060 |
Why?
| | South America | 1 | 2025 | 57 | 0.060 |
Why?
| | Postprandial Period | 2 | 1997 | 114 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 57 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2011 | 779 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 97 | 0.050 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 33 | 0.050 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2025 | 78 | 0.050 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 134 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2015 | 932 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1070 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 148 | 0.050 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 39 | 0.050 |
Why?
| | Gastroplasty | 1 | 2004 | 32 | 0.050 |
Why?
| | Schools | 1 | 2007 | 453 | 0.050 |
Why?
| | Health Behavior | 2 | 2023 | 788 | 0.050 |
Why?
| | Spleen | 2 | 2020 | 511 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2026 | 782 | 0.050 |
Why?
| | Delivery of Health Care | 2 | 2022 | 948 | 0.050 |
Why?
| | Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 34 | 0.050 |
Why?
| | Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| | Hot Temperature | 1 | 2026 | 411 | 0.050 |
Why?
| | Palm Oil | 1 | 2002 | 3 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2022 | 6 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 18 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5989 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2023 | 143 | 0.050 |
Why?
| | Oxides | 1 | 2022 | 49 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 83 | 0.040 |
Why?
| | Genetic Engineering | 1 | 2002 | 89 | 0.040 |
Why?
| | Reference Standards | 1 | 2002 | 178 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 411 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 405 | 0.040 |
Why?
| | Community Health Services | 1 | 2023 | 231 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 738 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 216 | 0.040 |
Why?
| | Magnesium | 2 | 2001 | 156 | 0.040 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 39 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 890 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2009 | 1153 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 2 | 2019 | 83 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 1985 | 512 | 0.040 |
Why?
| | Orosomucoid | 1 | 2020 | 9 | 0.040 |
Why?
| | Metallothionein | 1 | 2000 | 26 | 0.040 |
Why?
| | Vaccination | 2 | 2022 | 1423 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 360 | 0.040 |
Why?
| | Licensure | 1 | 2019 | 16 | 0.040 |
Why?
| | Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| | Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2945 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 552 | 0.040 |
Why?
| | Colombia | 1 | 2019 | 43 | 0.040 |
Why?
| | Peru | 1 | 2019 | 62 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 224 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 103 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 443 | 0.040 |
Why?
| | Accreditation | 1 | 2019 | 101 | 0.040 |
Why?
| | Family Relations | 1 | 2000 | 88 | 0.040 |
Why?
| | Brazil | 1 | 2019 | 183 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 25 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2018 | 12 | 0.040 |
Why?
| | HIV Infections | 1 | 2014 | 3189 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2019 | 79 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 1998 | 74 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Rhinitis, Allergic | 1 | 2019 | 42 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2594 | 0.040 |
Why?
| | Eczema | 1 | 2019 | 66 | 0.030 |
Why?
| | Organ Specificity | 2 | 2014 | 312 | 0.030 |
Why?
| | Microwaves | 1 | 1998 | 29 | 0.030 |
Why?
| | Focus Groups | 1 | 2021 | 569 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2019 | 282 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 88 | 0.030 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 296 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1082 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2020 | 422 | 0.030 |
Why?
| | Hospitals, Maternity | 1 | 2017 | 4 | 0.030 |
Why?
| | Pressure | 1 | 1998 | 226 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 163 | 0.030 |
Why?
| | Food-Drug Interactions | 1 | 2017 | 11 | 0.030 |
Why?
| | Tuberculosis | 1 | 2000 | 292 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2019 | 538 | 0.030 |
Why?
| | Fermentation | 1 | 2017 | 32 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 187 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 13 | 0.030 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 164 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 296 | 0.030 |
Why?
| | Phosphates | 1 | 1997 | 177 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 28 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 269 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1997 | 276 | 0.030 |
Why?
| | Community Health Centers | 1 | 2016 | 59 | 0.030 |
Why?
| | Computer Simulation | 1 | 2000 | 1026 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Kidney | 2 | 2020 | 1498 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 404 | 0.030 |
Why?
| | Dermatitis, Atopic | 1 | 2019 | 323 | 0.030 |
Why?
| | Reproductive Behavior | 1 | 2015 | 11 | 0.030 |
Why?
| | RNA, Viral | 1 | 2019 | 693 | 0.030 |
Why?
| | Pancreas | 1 | 1998 | 341 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 673 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2129 | 0.030 |
Why?
| | Dental Caries | 1 | 2016 | 173 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1769 | 0.030 |
Why?
| | Medical History Taking | 1 | 1995 | 117 | 0.030 |
Why?
| | Students, Medical | 1 | 2019 | 375 | 0.030 |
Why?
| | Absorption, Physiological | 1 | 2014 | 4 | 0.030 |
Why?
| | Vaccines, Conjugate | 1 | 2014 | 59 | 0.030 |
Why?
| | Fetal Proteins | 1 | 1994 | 15 | 0.030 |
Why?
| | Insulin-Like Growth Factor II | 1 | 1994 | 24 | 0.030 |
Why?
| | Kinetics | 3 | 2007 | 1605 | 0.030 |
Why?
| | Serum Albumin | 3 | 1999 | 144 | 0.030 |
Why?
| | Health | 1 | 2014 | 81 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2015 | 170 | 0.030 |
Why?
| | Bacteria | 1 | 2020 | 897 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2020 | 739 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2014 | 335 | 0.020 |
Why?
| | Estradiol | 1 | 1997 | 507 | 0.020 |
Why?
| | Physical Examination | 1 | 1995 | 243 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 2014 | 170 | 0.020 |
Why?
| | Uruguay | 1 | 2013 | 2 | 0.020 |
Why?
| | Amino Acids | 1 | 1997 | 521 | 0.020 |
Why?
| | Pregnancy, Twin | 1 | 2013 | 19 | 0.020 |
Why?
| | Contraception | 1 | 2015 | 170 | 0.020 |
Why?
| | Hypertension | 2 | 2016 | 1273 | 0.020 |
Why?
| | Morbidity | 1 | 2014 | 322 | 0.020 |
Why?
| | Lung | 2 | 2020 | 4103 | 0.020 |
Why?
| | Fetal Mortality | 1 | 2012 | 4 | 0.020 |
Why?
| | DNA Replication | 1 | 1994 | 252 | 0.020 |
Why?
| | South Australia | 1 | 2011 | 4 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1058 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1999 | 831 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.020 |
Why?
| | Healthy Volunteers | 1 | 2012 | 218 | 0.020 |
Why?
| | Breath Tests | 1 | 2011 | 77 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | Sucrose | 1 | 2011 | 115 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2011 | 144 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 282 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 343 | 0.020 |
Why?
| | Risk | 1 | 2013 | 917 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 518 | 0.020 |
Why?
| | Swimming | 1 | 2009 | 54 | 0.020 |
Why?
| | Ovalbumin | 1 | 2009 | 194 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2009 | 226 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 316 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 579 | 0.020 |
Why?
| | Corticosterone | 1 | 2009 | 242 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1081 | 0.020 |
Why?
| | Protein Deficiency | 1 | 2007 | 4 | 0.020 |
Why?
| | Interleukins | 1 | 2009 | 249 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2009 | 315 | 0.020 |
Why?
| | Mice | 2 | 2018 | 18338 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 1795 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2009 | 636 | 0.020 |
Why?
| | Counseling | 1 | 2010 | 405 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1261 | 0.020 |
Why?
| | Self Efficacy | 1 | 2010 | 409 | 0.010 |
Why?
| | Food, Genetically Modified | 1 | 2006 | 2 | 0.010 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 29 | 0.010 |
Why?
| | Plants, Genetically Modified | 1 | 2006 | 15 | 0.010 |
Why?
| | Biliary Atresia | 1 | 1987 | 158 | 0.010 |
Why?
| | Sweat | 1 | 1986 | 51 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 480 | 0.010 |
Why?
| | Gallstones | 1 | 2005 | 35 | 0.010 |
Why?
| | Antimalarials | 1 | 2005 | 35 | 0.010 |
Why?
| | Chloroquine | 1 | 2005 | 54 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 193 | 0.010 |
Why?
| | Isotope Labeling | 1 | 2005 | 83 | 0.010 |
Why?
| | Mental Competency | 1 | 2004 | 26 | 0.010 |
Why?
| | Parental Consent | 1 | 2004 | 25 | 0.010 |
Why?
| | Anorexia | 1 | 1984 | 16 | 0.010 |
Why?
| | Family Characteristics | 1 | 2005 | 198 | 0.010 |
Why?
| | Primary Prevention | 1 | 2005 | 218 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2005 | 271 | 0.010 |
Why?
| | Informed Consent | 1 | 2004 | 197 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 679 | 0.010 |
Why?
| | Gastrointestinal Transit | 1 | 2002 | 6 | 0.010 |
Why?
| | Body Fluid Compartments | 1 | 2002 | 6 | 0.010 |
Why?
| | Free Radicals | 1 | 2001 | 110 | 0.010 |
Why?
| | Radioactive Tracers | 1 | 2000 | 5 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 222 | 0.010 |
Why?
| | Mass Screening | 1 | 2010 | 1358 | 0.010 |
Why?
| | Phosphorus | 1 | 2001 | 98 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 54 | 0.010 |
Why?
| | Urine | 1 | 2000 | 64 | 0.010 |
Why?
| | Blood | 1 | 2000 | 107 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 742 | 0.010 |
Why?
| | Diabetes Complications | 1 | 2001 | 223 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8326 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2004 | 775 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4559 | 0.010 |
Why?
| | Eating | 1 | 2000 | 388 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 351 | 0.010 |
Why?
| | Creatinine | 1 | 1999 | 513 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1040 | 0.010 |
Why?
| | Software | 1 | 2000 | 698 | 0.010 |
Why?
| | North America | 1 | 1995 | 312 | 0.010 |
Why?
| | Europe | 1 | 1995 | 421 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1816 | 0.010 |
Why?
| | Sheep | 1 | 1994 | 882 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1989 | 227 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1994 | 4127 | 0.000 |
Why?
| | Urinary Tract Infections | 1 | 1989 | 210 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1994 | 2820 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1989 | 330 | 0.000 |
Why?
| | Blood Proteins | 1 | 1983 | 230 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|